Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ CYP7A1 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA515216
Description
This antibody is predicted to react with rabbit based on sequence homology.
CYP7A1 is a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This endoplasmic reticulum membrane protein catalyzes the first reaction in the cholesterol catabolic pathway in the liver, which converts cholesterol to bile acids. This reaction is the rate limiting step and the major site of regulation of bile acid synthesis, which is the primary mechanism for the removal of cholesterol from the body.
Specifications
CYP7A1 | |
Polyclonal | |
Unconjugated | |
Cyp7a1 | |
24-hydroxycholesterol 7-alpha-hydroxylase; CHAP; cholesterol 7 alpha hydroxylase; cholesterol 7-alpha hydroxylase; cholesterol 7-alpha-hydroxylase; Cholesterol 7-alpha-monooxygenase; CP7A; CYP7; Cyp7a1; CYP7S1; CYPVII; cytochrome P450 (cholesterol hydroxylase 7 alpha); cytochrome P450 7A1; cytochrome P450 family 7 subfamily A member 1; cytochrome P450, 7a1; cytochrome P450, family 7, subfamily a, polypeptide 1; cytochrome P450, subfamily VIIA polypeptide 1 | |
Rabbit | |
Ammonium Sulfate Precipitation, Size-exclusion - Dialysis | |
RUO | |
1581 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Western Blot | |
2 mg/mL | |
PBS with 0.09% sodium azide; pH 7.4 | |
P22680 | |
Cyp7a1 | |
KLH conjugated synthetic peptide between 476-504 amino acids from the C-terminal region of human CYP7A1. | |
400 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction